Race Definitions Have Limited Impact on Cancer Rates in Whites, Blacks, Asians
By Elana Gotkine HealthDay Reporter

MONDAY, July 21, 2025 -- Race definitions have limited impact on cancer rates for Whites, Blacks, and Asians, but do impact rates in multiracial individuals, according to a study published online July 21 in Cancer.
Mandi Yu, Ph.D., from the National Cancer Institute in Bethesda, Maryland, and colleagues obtained cancer incidence rates from the National Cancer Institute Surveillance, Epidemiology, and End Results Program and cancer deaths from the National Vital Statistics System. Rate ratios were used to compare age-standardized rates of incidence and mortality in 2020 across three definitions: two definitions compliant with the 1997 Office of Management and Budget (OMB) standards (race-alone and race-alone-or-in-combination) and one compliant with the previous 1977 OMB standard (bridged-race).
The researchers found that compared with the population data, the proportions of multiracial individuals were lower in the incidence and death data, with the degree varying by age, race, and geography. For Whites, Blacks, and Asians, race definitions had minimal impact on rates. For Native Hawaiians or other Pacific Islanders (NHOPIs), race-alone-or-in-combination rates were lower compared with race-alone rates, indicating an underrepresentation of multiracial NHOPI individuals in incidence data. For American Indians/Alaskan Natives (AI/ANs), race-alone and race-alone-or-in-combination yielded similar rates, but they were significantly lower than their bridged-rate counterparts, indicating a mismatch in classification of AI/AN between incidence and population data.
"Enhancing the accuracy of patients' self-reported racial identification and incorporating multiracial classifications into hospital data collection systems are essential steps for improving the comparability between cancer incidence and census-based population data," Yu said in a statement.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-07-22 12:00
Read more

- Apogee Therapeutics Announces Positive 16-Week Data from Phase 2 APEX Clinical Trial of APG777, its Potentially Best-in-Class Anti-IL-13 Antibody, in Moderate-to-Severe Atopic Dermatitis
- FDA Approves Harliku (nitisinone) for the Treatment of Patients with Alkaptonuria
- New Stem Cell Approach Helps Transplant Patients Drop Immune-Suppressing Drugs
- U.S. Hospitals Face Shortages in Essential Staff Due to Foreign Residency Visa Delays
- Diet Influences Constipation Risk, Study Says
- Telehealth Intervention Beneficial for Seniors With Metastatic Cancer
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions